Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

1,947 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,947 results

Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Testing effectiveness (Phase 2)Study completedNCT05004038
What this trial is testing

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:

Who this might be right for
HIV-1-infection
University of Zurich 60
Testing effectiveness (Phase 2)Study completedNCT00654147
What this trial is testing

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Who this might be right for
HIV Infections
Margaret A. Fischl, M.D. 44
Early research (Phase 1)Study completedNCT00002363
What this trial is testing

The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Columbia Research Laboratories 20
Testing effectiveness (Phase 2)Study completedNCT00848211
What this trial is testing

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Thymon, LLC 24
Large-scale testing (Phase 3)Study completedNCT05306704
What this trial is testing

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial

Who this might be right for
HIV-1-infectionHypovitaminosis D
University of the Punjab 95
Testing effectiveness (Phase 2)Ended earlyNCT02239835
What this trial is testing

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 79
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Post-approval studies (Phase 4)UnknownNCT03774108
What this trial is testing

Metformin and Systemic Inflammation in HIV

Who this might be right for
PreDiabetesHIV-1-infection
Hospital Civil de Guadalajara 40
Early research (Phase 1)Study completedNCT00000782
What this trial is testing

A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Not applicableStudy completedNCT00029913
What this trial is testing

Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials

Who this might be right for
HIV Infections
HIV Vaccine Trials Network 54
Early research (Phase 1)Study completedNCT00004579
What this trial is testing

See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR)
Testing effectiveness (Phase 2)Ended earlyNCT00090779
What this trial is testing

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 130
Not applicableStudy completedNCT06285110
What this trial is testing

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

Who this might be right for
Hiv
University of Bern 1,103
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Not applicableStudy completedNCT04596488
What this trial is testing

Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients

Who this might be right for
HIV-1-infection
Peking Union Medical College Hospital 25
Large-scale testing (Phase 3)Study completedNCT00046176
What this trial is testing

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 240
Next Page